Skip to content

Yoga for chronic Neurological Disorders

Effect of Yoga on on Neurological Disorders:(Headache, Parkinsons Disease and Stroke) A Randomized control Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/053346
Enrollment
450
Registered
2023-05-31
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G894- Chronic pain syndrome Health Condition 2: G20- Parkinsons disease Health Condition 3: I698- Sequelae of other cerebrovasculardiseases

Interventions

Intervention1: Yoga: A yoga Module for all three different disease conditions are implemented Frequency of Intervention: 1 hour, 3 days per week for every for 6 months Control Intervention1: Sta

Sponsors

BHU
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients recruitment from OPD, IMS participants who can give written consent. Migraine with or without aura, Tension type headache & Trigeminal Autonomic Cephalalgias (TAC) Stroke: mRS Score, stage 0,1, 2 and 3, Less than 6 months after stroke, atherosclerosis Ischemic Stroke, TIA (transient Ischemic attack or mini stroke), Haemorrhage stroke patients for example obesity, smoking, because of unhealthy life style People have a capacity to walk or run without the use of a walking aid or walking stick/wheel chair PD: stage I to III on the Hoehn and Yahr scale People have a capacity to walk or run without the use of a walking aid or walking stick/wheel chair

Exclusion criteria

Exclusion criteria: Who refuses Consent, or skip in between the Given time point. Headache: Headache patients with Cough, any Headache due to ear, Nose, Throat infection Chronic Head issues like injured head etc. Stroke: mRS score 4 and 5, Sever stage of Haemorrhagic stroke. current involvement in any other behavioural pharmaceutical, or instructor-led exercise trials who are undergoing mental health treatment or have uncontrolled mood problems PD: IV Patients on wheel chair, V- Bed Ridden Patients current involvement in any other behavioural pharmaceutical, or instructor-led exercise trials who are undergoing mental health treatment or have uncontrolled mood problems

Design outcomes

Primary

MeasureTime frame
Headache: Headache Intensity, Headache Frequency, HIT-6, MIDAS, Serum CGRP, HADS, QoL PD: UPDRS III, TUG test, PDQ-8, Mobility and Balance, NMS Scale, HADS, QoL Stroke: mRS, Barthal Index, Chair Stand test, Arm Curt Test, 2 min step test, 6 min walk test, PEG test, ABC Scale, Ashworth for Spasticity, QoL Timepoint: 6 months

Secondary

MeasureTime frame
Headache: Serum CGRP, HADS, QoL PD: NMS Scale, HADS, QoL Stroke: ABC Scale, Ashworth for Spasticity, QoL Timepoint: 6 months

Countries

India

Contacts

Public ContactDr Anand Kumar

Banaras Hindu University

anandneuro@bhu.ac.in9654301595

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026